Zobrazeno 1 - 8 of 8 pro vyhledávání: '"Hamid Amouzadeh"'
1
Akademický článek
Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study
Autor: Yukari Okubo, Tadashi Terui, Satomi Kobayashi, Shigetoshi Sano, Akimichi Morita, Shinichi Imafuku, Yayoi Tada, Masatoshi Abe, Masafumi Yaguchi, Takeshi Kimura, Junichiro Shimauchi, Wendy Zhang, Hamid Amouzadeh, Masamoto Murakami
Publikováno v: Dermatology and Therapy, Vol 14, Iss 7, Pp 1863-1873 (2024)
Abstract Introduction Palmoplantar pustulosis (PPP) is a pruritic, painful, chronic dermatitis that greatly impacts functioning and quality of life and can be difficult to treat. Approved treatment options for PPP are limited, and many patients do no
Externí odkaz: https://doaj.org/article/34a2089061c64c6f827972a89c82714f
Zobrazit plný text záznamu
2
Akademický článek
Consistent Efficacy of Apremilast in Patients with Psoriasis Regardless of Baseline Disease Severity or Special Area Involvement: Subgroup Analysis from PROMINENT
Autor: Masatoshi Abe, Yukari Okubo, Hidetoshi Takahashi, Koki Endo, Siddharth Chaudhari, Cynthia Deignan, Hamid Amouzadeh, Ryosuke Hino
Publikováno v: Dermatology and Therapy, Vol 14, Iss 6, Pp 1587-1597 (2024)
Abstract Introduction Psoriasis involvement in special areas (e.g., scalp or nails) is associated with a great disease burden yet it is often inadequately treated with topical treatments. The efficacy and tolerability of apremilast plus existing topi
Externí odkaz: https://doaj.org/article/fbf2624c5e1844fd9ab4f4c5900a4560
Zobrazit plný text záznamu
3
Akademický článek
Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study.
Autor: Okubo, Yukari1 (AUTHOR) yukari-o@tokyo-med.ac.jp, Terui, Tadashi2 (AUTHOR), Kobayashi, Satomi3 (AUTHOR), Sano, Shigetoshi4 (AUTHOR), Morita, Akimichi5 (AUTHOR), Imafuku, Shinichi6 (AUTHOR), Tada, Yayoi7 (AUTHOR), Abe, Masatoshi8 (AUTHOR), Yaguchi, Masafumi9 (AUTHOR), Kimura, Takeshi9 (AUTHOR), Shimauchi, Junichiro9 (AUTHOR), Zhang, Wendy10 (AUTHOR), Amouzadeh, Hamid10 (AUTHOR), Murakami, Masamoto11 (AUTHOR)
Publikováno v: Dermatology & Therapy. Jul2024, Vol. 14 Issue 7, p1863-1873. 11p.
Zobrazit plný text záznamu
4
Akademický článek
Consistent Efficacy of Apremilast in Patients with Psoriasis Regardless of Baseline Disease Severity or Special Area Involvement: Subgroup Analysis from PROMINENT.
Autor: Abe, Masatoshi1 (AUTHOR) masaabe@kojinkai.org, Okubo, Yukari2 (AUTHOR), Takahashi, Hidetoshi3 (AUTHOR), Endo, Koki4 (AUTHOR), Chaudhari, Siddharth5 (AUTHOR), Deignan, Cynthia6 (AUTHOR), Amouzadeh, Hamid6 (AUTHOR), Hino, Ryosuke7,8 (AUTHOR)
Publikováno v: Dermatology & Therapy. Jun2024, Vol. 14 Issue 6, p1587-1597. 11p.
Zobrazit plný text záznamu
6
Akademický článek
Expected spesolimab plasma exposure following intravenous and subcutaneous dosing in patients with generalized pustular psoriasis.
Publikováno v: Journal of Clinical & Aesthetic Dermatology. 2024 Suppl, Vol. 17, pS32-S33. 2p.
Zobrazit plný text záznamu
7
Akademický článek
Efficacy and safety of a small molecule with innovative inhibition of TNFR1 signaling in plaque psoriasis: a doubleb-linded, randomized, placebo-controlled study.
Publikováno v: Journal of Clinical & Aesthetic Dermatology. 2024 Suppl, Vol. 17, pS31-S32. 2p.
Zobrazit plný text záznamu
8
Akademický článek
Efficacy and safety of apremilast in pediatric patients with moderate-to-severe plaque psoriasis: 52-week results from the SPROUT randomized controlled trial.
Publikováno v: Journal of Clinical & Aesthetic Dermatology. 2024 Suppl, Vol. 17, pS32-S32. 1/2p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje